Gyre Pharmaceuticals has completed participant enrolment for its 52-week Phase III clinical trial assessing Pirfenidone ...

Governments have been pushing the construction of apartment towers for years to help housing affordability and availability, ...

The impact of men’s heavy drinking on children has been even less well studied than its effect on women. Yet our research ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

The UK government has announced up to £50 million for groundbreaking mental health research, aiming to deliver more effective ...

Researchers from the University of Liverpool have secured a £2.4 million grant to improve treatments for keratoconus ...

The University of Birmingham leads £1.55m research to assess the long-term effects of vaping on respiratory cells, immunity, ...

A Nature study shows sperm from older fathers carry more disease-linked mutations, revealing how age and cell competition ...

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionize how ...

Combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body’s natural response to viral infections, showed promising results in patients with relapsed or refractory natural ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...